Akorn Provides Third Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
Go back to Akorn Provides Third Quarter 2016 Results
November 7, 2016 1:46 PM EST
Deutsche Bank upgraded Akorn (NASDAQ: AKRX) from Hold to Buy with a price target of $28. Analyst Gregg Gilbert said its sell-off was overdone.
"AKRX shares are down 20% since 11/3, when the company reported 3Q results and news emerged about a DOJ investigation into suspected price collusion involving generic companies that could... More
November 7, 2016 7:13 AM EST
BofA/Merrill Lynch downgraded Akorn (NASDAQ: AKRX) from Buy to Underperform with a price target of $22.00.
For an analyst ratings summary and ratings history on Akorn click here. For more ratings news on Akorn click here.
Shares of Akorn closed at $19.68 yesterday.
...
More
November 4, 2016 9:52 AM EDT
Jefferies maintained a Buy rating on Akorn (NASDAQ: AKRX), and cut the price target to $24.00 (from $35.00), following the company's 3Q earnings report. Jefferies lowered estimates as re-inspection issues create more uncertainty. Assuming a 6 month delay expected revenues from pipeline products... More
November 4, 2016 6:13 AM EDT
RBC Capital downgraded Akorn (NASDAQ: AKRX) from Outperform to Sector Perform with a price target of $24.00 (from $37.00) on a higher risk profile and challenged P&L visibility.
Analyst Randall Stanicky commented, "As previewed on Monday, we entered 3Q looking for better clarity around FDA... More
